Gaëtan Devos

82 posts

Gaëtan Devos banner
Gaëtan Devos

Gaëtan Devos

@devos_gaetan

MD, PhD - Urology resident @UZLeuven @azsintjanbrugge #ProstateCancer

Katılım Ağustos 2018
311 Takip Edilen293 Takipçiler
Sabitlenmiş Tweet
Gaëtan Devos
Gaëtan Devos@devos_gaetan·
Very proud to present the ARNEO study published in @EUplatinum!! In high-risk PCa patients, neoadjuvant degarelix plus apalutamide prior to RP results in significantly improved pathological response compared to degarelix alone! @joniau A thread🧵👇: authors.elsevier.com/c/1fow714kplrK…
English
3
49
136
0
Gaëtan Devos retweetledi
European Urology
European Urology@EUplatinum·
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer by Gaëtan Devos et al Full article: europeanurology.com/article/S0302-…
English
0
13
30
6.9K
Gaëtan Devos retweetledi
Sabine D. Brookman-May
Sabine D. Brookman-May@brookmans76·
Congratulations again to #ARNEO study @devos_gaetan @joniau @TheGiesen ▶️MRD doesn't predict BCR ▶️We will need to wait for a possible significant impact on MFS with longer FU ▶️ypT stage correlates with outcomes 👉 Did downstaging after neoadjuvant treatment correlate with BCR?
Gaëtan Devos@devos_gaetan

Today we presented the 3 year oncological outcomes of the ARNEO trial: - Patients treated with 3 mo neoadjuvant ADT + Apalutamide have tendency towards improved BCR free and metastasis free survival. - pT2 disease associated with less biochemical recurrence. @joniau @TheGiesen

English
1
5
12
1.9K
Gaëtan Devos
Gaëtan Devos@devos_gaetan·
Today we presented the 3 year oncological outcomes of the ARNEO trial: - Patients treated with 3 mo neoadjuvant ADT + Apalutamide have tendency towards improved BCR free and metastasis free survival. - pT2 disease associated with less biochemical recurrence. @joniau @TheGiesen
UroToday.com@urotoday

Three-year oncological outcomes of the randomized phase II trial #ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for HR #ProstateCancer. Presented by @devos_gaetan @UZLeuven. #EAU24 written coverage > bit.ly/3TNxJxI @RKSayyid

English
1
5
23
3.7K
Gaëtan Devos
Gaëtan Devos@devos_gaetan·
Nice work by @KarelDavid_ ! Three months of neoadjuvant ADT in high-risk PCa patients results in early bone loss. These findings underscore the importance for bone health prevention in men treated with ADT . @Uroweb @UZLeuven
Karel David@KarelDavid_

Happy to see our work highlighted during this #Movember month! Don't forget the impact of #androgendeprivation on #bone in #prostatecancer patients! bit.ly/3G3LKkd Great collaboration with our urology department @devos_gaetan @WoutDevlies @joniau 👇👇👇

English
0
0
5
412
Gaëtan Devos retweetledi
Sabine D. Brookman-May
Sabine D. Brookman-May@brookmans76·
Great presentation of #ARNEO results by @joniau #UroOnco23 Neoadjuvant treatment apa/ADT vs ADT prior to RP in #prostatecancer: BCR not sign. different yet + MRD does not seem to be a good surrogate for BCR. But: downstaging to pT2 was higher with apa/ADT + correlated with BCR
Sabine D. Brookman-May tweet mediaSabine D. Brookman-May tweet mediaSabine D. Brookman-May tweet mediaSabine D. Brookman-May tweet media
English
1
10
45
7.5K
Gaëtan Devos retweetledi
Gert De Meerleer
Gert De Meerleer@GertMeerleer·
Excellent PhD defense by Gaetan Devos. New treatment options in high-risk prostate cancer and a new proof of the power of metastatis-directed therapy in oligometastatic prostate cancer. Proud to be copromotor 🙏 #respect #prostate #cancer #SBRT #oligo ⁦@joniau⁩ ⁦
Gert De Meerleer tweet media
English
0
2
20
0
Gaëtan Devos retweetledi
Ignacio Rguez. Gomez
Ignacio Rguez. Gomez@urogomez_·
Great job¡¡¡ Congrats to the UH Leuven...steps to a new therapeutic scenario in HR PCa...@joniau @devos_gaetan @GertMeerleer @EveraertsW @heinvanpoppel Lorenzo Tosco,Carl Van Haute et al
European Urology@EUplatinum

ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer buff.ly/3dMB7rB @devos_gaetan @joniau @HendrikPoppel @GertMeerleer

English
0
2
3
0

Keşfet

@joniau @TheGiesen @vandamme_jvd @sb_uro @Uroweb @esru_be @KarelDavid_ @UZLeuven